Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients [Phase 3]
A Phase 3 clinical trial evaluating tacrolimus ointment for adult atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis [Phase 2]
This Phase 2 clinical trial evaluated the pharmacokinetics of tacrolimus ointment in infants with atopic dermatitis and has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Protopic Ointment in Children Atopic Eczema [Phase 4]
Phase 4 trial update showing completion of the pediatric study of Protopic Ointment (tacrolimus) for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Protopic Ointment in Adult Atopic Eczema of the Face [Phase 4]
A Phase 4 trial evaluating tacrolimus ointment (Protopic) for adult atopic dermatitis on the face has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Exploratory Study of Natural Killer Cells in Human Skin [NA]
Clinical trial update indicates completion of an exploratory study of natural killer cells in human skin, covering Atopic dermatitis, Contac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update showing Locobase REPAIR used as an adjunct to standard therapy in children with moderate to severe atopic derm…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis [NA]
Bayer-sponsored completed clinical trial evaluating a new revised topical formulation for atopic dermatitis, focusing on efficacy and safety…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis [Phase 4]
Phase 4 clinical trial evaluating preventive use of tacrolimus ointment in children with moderate-to-severe atopic dermatitis; the study has…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis [NA]
Clinical trial update noting the completion of a pediatric study comparing two topical corticosteroid regimens for atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Cutivate Lotion HPA Axis Pediatric Study [Phase 4]
Phase 4 pediatric HPA axis study of Cutivate Lotion (fluocinonide) for atopic dermatitis has completed and results were posted in 2014.
-
FDA approval · 2014-07-18FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, updating or expanding its labeling.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Topical Application of AS101 for the Treatment of Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating topical AS101 for atopic dermatitis was terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream [Phase 2]
Phase 2 trial evaluating the duration of use experience with Alclometasone Dipropionate Cream has completed with results posted in 2014.
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's Original Application for fluocinonide, a topical corticosteroid, as a generic product. This marks regulatory cle…
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an original application for fluocinonide from Sun Pharmaceutical Industries, a topical corticosteroid. The product is indicated…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients [Phase 3]
This document reports the completion of a Phase 3 trial of WAL 801 CL Dry Syrup in pediatric patients with atopic dermatitis. The study, spo…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients [Phase 3]
A Phase 3 trial of WAL 801 CL Dry Syrup for paediatric atopic dermatitis has completed, according to the trial update from Boehringer Ingelh…
-
CLINICAL_TRIALS withdrawal · 2014-06-27Clinical Trial Update: Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects [Phase 3]
A Phase 3 pediatric trial evaluating Product 0405 versus vehicle control for mild-to-moderate atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-27Clinical Trial Update: Study to Determine the Pharmacokinetics of Product 0405 [Phase 3]
A Phase 3 pharmacokinetics study of Product 0405 sponsored by Fougera Pharmaceuticals Inc. for Atopic Dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-27Clinical Trial Update: Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects [Phase 3]
A Phase 3 study evaluating Product 0405 versus vehicle control for mild-to-moderate atopic dermatitis in pediatric patients has been withdra…
-
CLINICAL_TRIALS research · 2014-06-23Clinical Trial Update: Atopic Dermatitis Adherence Study [NA]
Update on an ongoing clinical trial studying adherence in atopic dermatitis; no status or phase information is provided.
-
FDA approval · 2014-06-19FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, indicating approval of a supplemental for…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial comparing the potential atrophogenic effects of hydrocortisone 1% cream versus pimecrolimus 1% cream on uninvolved sk…
-
FDA approval · 2014-06-04FDA Approved: PIMECROLIMUS — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Pimecrolimus from Oceanside Pharmaceuticals.
-
FDA approval · 2014-06-03FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) from Chartwell RX, LLC.